Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

163 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Active, not recruiting

COVID-19 Vaccine Responses in PIDD Subjects

NCT05321407

Conditions
Bruton type agammaglobulinemia, COVID-19, CVID, +22 more
Locations
  • University of South Florida St. Petersburg, Florida, United States
  • University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Active, not recruiting

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

NCT03475212

Conditions
Adenoviridae Infections, Adenovirus Infection, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 30 locations
View Trial Details
Active, not recruiting

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

NCT03301168

Conditions
Acute Lymphoblastic Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Completed

An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)

NCT07076446

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Research Solutions of AZ Litchfield Park, Arizona, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • Immunoe Health Centers Centennial, Colorado, United States
  • Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
View Trial Details
Completed

Study of PlasmaCap IG in Adults and Children With PIDD

NCT03238079

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • University of California Los Angeles, California, United States
  • IMMUNOe Health & Research Centers Centennial, Colorado, United States
  • University of South Florida Tampa, Florida, United States
  • Allergy Associates of the Palm Beaches, P.A. West Palm Beach, Florida, United States
View Trial Details
Completed

A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants

NCT05513586

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Hospital of University of Occupational and Environmental Health Kitakyushu, Fukuoka, Japan
  • Kanagawa Children's Medical Center Yokohama, Kanagawa, Japan
  • Tokyo Medical Dental University Hospital Bunkyo-ku, Tokyo, Japan
View Trial Details

Related conditions